Contact Us
Quotes News NAV
Market Watch
01 Oct EOD
SENSEX
NIFTY
GOLD
SILVER
CRUDE OIL
 
Market Info EXPAND TICKER
You are here : Corporate Information   |  Company News
Your Result on : Corporate Information | Company News
Date Headline
23-Sep-2026 Natco Pharma to consider Fund Raising
09-Sep-2026 Natco Pharma board approves rights issue of Rs 1,300 cr
05-Sep-2026 Natco Pharma to conduct board meeting
05-Sep-2026 Natco Pharma to conduct AGM
25-Aug-2026 Natco Pharma to further invest USD 14M in eGenesis Inc.
24-Aug-2026 Stock Alert: Caplin Point Lab, Natco pharma, Federal Bank, B. R. Goyal Infra
22-Aug-2026 Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit
22-Aug-2026 NATCO Pharma's Visakhapatnam unit gets Form 483 with 4 observations from US FDA
14-Aug-2026 Board of Natco Pharma recommends interim dividend
14-Aug-2026 National Aluminium Company Ltd leads losers in 'A' group
<< < 1 2 > >> 
Detailed Quotes
MF Holdings
Company News
Profit and Loss
Quarterly Results
Share Holding Pattern
Deliverable Volumes
Historical Prices
Board of Directors
Director's Report
Peer Comparison
Score Board
Name Change
Financial Ratios
Company Background
Company Snapshot
Balance Sheet
Site Map | Disclaimer | Circular Reports | Research Reports | About Us | Feedback | Careers | Contact Us
Useful Links
Stock : Stock Price Quotes | Stock Market India | Stock Market Global | Corporate Announcement
Market News : Corporate News | Market Commentary | Corporate Results | Economy News | Other Markets | Hot Pursuit | Futures Market
Share Market Updates : BSE Top Gainers - Sensex | NSE Top Gainers - Nifty | BSE Top Losers - Sensex | NSE Top Losers - Nifty | BSE Most Active Scrip by Volume - Sensex |
NSE Most Active Scrip by Volume - Nifty | BSE Most Active Scrip by Value - Sensex | NSE Most Active Scrip by Value - Nifty | Advances and Declinces
Derivatives : Get Quotes | Daily Settlement Prices | Put-Call Ratio | Cost Of Carry
Global Indicator : Stock Market Global | Currency | ADR Prices | FII Investments | Mutual Fund Investments
Services : Equity | Derivatives | Commodities | Mutual Fund | Portfolio Management Services (PMS) | Initial Public Offer (IPO)
Members:
Sebi Regn.No. - BSE : INB010983738 | NSE : INB230983737 | F&O : INF230983737 | NSE Currency: INE230983737 | FMC REGN.MCX : MCX/TCM/CORP/0276 | NCDEX : NCDEX/TCM/CORP/0411
Email ID for redressal of Investor Complaints : investorgrievances@manumangal.com
2012 © MANUBHAI MANGALDAS SECURITIES PVT. LTD All rights reserved Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)